Home › Colorectale kanker › Texas › Dallas
Colorectale kanker klinische studies in Dallas, TX
33 studies voor Colorectale kanker zoeken deelnemers op locaties in en rond Dallas (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- UT Southwest Simmons Cancer Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #89, Dallas
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
RekruterenFase 1
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RekruterenFase 3
- Parkland Health and Hospital System, Dallas
- Texas Oncology DFW, Dallas
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
RekruterenFase 1
- GSK Investigational Site, Dallas
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RekruterenFase 1
- Research Site, Dallas
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RekruterenFase 3
- Texas Oncology DFW, Dallas
- UT Southwestern, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruterenFase 1/2
- Baylor, Scott and White Research Institute, Dallas
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
RekruterenFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruterenFase 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruterenFase 1
- Texas Oncology - DFW (Sammons CC), Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekruterenFase 1
- NEXT - Dallas, Dallas
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruterenFase 3
- University of Texas Southwestern Medical Center, Dallas
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekruterenFase 3
- Clinical Study Site, Dallas
- Clinical Study Site, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Texas Oncology, P.A., Dallas
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Texas Oncology, Dallas
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
RekruterenFase 3
- Texas Oncology - DFW, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RekruterenFase 2
- Texas Oncology - DFW, Dallas
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
RekruterenFase 4
- University of Texas Southwestern Medical Center, Dallas
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RekruterenFase 1/2
- University of Texas Southwestern Medical Center, Dallas
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Texas LLC - Dallas, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekruterenFase 1
- UT Southwestern Simmons Cancer Center, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruterenFase 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
RekruterenFase 1
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- Mary Crowley Cancer Research, Dallas
Early-Onset Colorectal Cancer Patients Too Young for Screening
RekruterenObservatieonderzoek
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
RekruterenFase 2
- NGM Clinical Study Site, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Oncology - Dallas, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
RekruterenFase 1/2
- NEXT Oncology Dallas, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RekruterenFase 4
- UT Southwestern Medical Center, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Dallas, Dallas
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekruterenFase 1
- NEXT Oncology, Dallas, Dallas
Colorectale kanker studies in andere steden
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Andere studies in Dallas
- Borstkanker55 studies
- Niet-kleincellige longkanker52 studies
- Metastatische kanker42 studies
- Hartfalen42 studies
- Kanker (alle vormen)37 studies
- Prostaatkanker36 studies
- Obesitas30 studies
- Eierstokkanker28 studies
- Longkanker27 studies
- Blasenkanker27 studies
- Endometriumkanker24 studies
- Nierkanker (niercelcarcinoom)23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.